RETRACTED: Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation
- 1 January 2004
- journal article
- retracted article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 483 (1), 79-93
- https://doi.org/10.1016/j.ejphar.2003.10.056
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory DrugsJournal of Biological Chemistry, 1997
- The PPARα–leukotriene B4 pathway to inflammation controlNature, 1996
- Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxideFEBS Letters, 1995
- Altered immune responses in mice lacking inducible nitric oxide synthaseNature, 1995
- Specificity of leukocyte-endothelial interactions and diapedesis: physiologic and therapeutic implications of an active decision processResearch in Immunology, 1993
- Degradation of human articular cartilage by neutrophils in synovial fluidArthritis & Rheumatism, 1993
- Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils.The Journal of cell biology, 1991
- Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardiumJournal of Pharmacological Methods, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Screens for anti-inflammatory drugsJournal of Pharmacy and Pharmacology, 1971